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Abstract 
Objective: Obesity is associated with an increased risk of developing 
Osteoarthritis (OA), which is postulated to be secondary to inflammation from 
adipose tissue (AT). There are peri-articular adipose depots in synovial joints, the 
association of this tissue with OA has not been extensively explored. The aim of 
this study was to investigate differences in local AT depots in knees with OA and 
changes related to class II and III obesity. 
Methods: Synovium and the infrapatellar fat pad (IPFP) were collected during 
total knee replacement from 69 patients with end-stage OA. The histological 
changes, adiponectin, PPARγ and TLR4 expression, and immune cell infiltration 
into AT, were investigated. 
Results: IPFP and synovium AT depots differed significantly and were influenced 
by the patient’s BMI. In obese patients’ adipocytes from IPFP were significantly 
larger while in the synovium, there was marked fibrosis, macrophage infiltration 
and higher TLR4 expression identified in comparison to lean subjects. Adipose 
related markers: PPARγ (in IPFP) and adiponectin and PPARγ (in synovium) 
were expressed at lower levels in obese compared to lean subjects. Furthermore, 
there was an increased number of CD45+ hematopoietic cells, CD45+CD14+, and 
CD14+CD206+ macrophages in both tissues in obese patients. 
Conclusions: These differences suggest that IPFP and synovium may contain two 
different white AT depots and supports the theory of inflammatory induced OA in 
class II and III obese patients. This warrant further investigation as a potentially 
reversible, or at least suppressible cause of OA in obese patients.  
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The prevalence of obesity (Body Mass Index (BMI) of 30 or greater) has 
significantly increased within developed societies over the last decade. It has been 
estimated that more than 50% of US adults will be obese by 2030 (1). Obesity, 
characterized by an excess of white adipose tissue due to an imbalance between 
calories consumed and expended, is associated with an increased risk of a number 
of diseases including type 2 diabetes mellitus (T2DM), atherosclerosis (2), and 
some types of cancer (3). There is also a recognized association between obesity 
and osteoarthritis (OA) (4) with obese individuals having a higher risk of 
developing OA of both weight bearing and non-weight bearing joints.  
 
Several mechanisms have been postulated by which obesity may initiate or 
accelerate the progression of OA. Biomechanical factors are likely to be important 
as weight bearing joints are overloaded, however, the increased incidence of OA 
in non-weight-bearing joints indicates that other factors are involved. It has been 
postulated that venous outlet obstruction in the subchondral bone might impair 
nutrient supply making articular cartilage more susceptible to damage (5). It is 
now becoming clear, however, that adipose tissue may create a systemic 
inflammatory milieu by releasing various cytokines and adipokines, which have 
the potential to damage articular cartilage directly (6). Furthermore, increasing 
BMI correlates with a higher content of free glycosaminoglycans (GAGs) in 
synovial fluid (7) and both hypercholesterolemia and hypertriglyceridemia have 
been hypothesized to interfere with cartilage metabolism (8). 
 
White adipose tissue depots are predominantly present in subcutaneous sites as 
subcutaneous adipose tissue (SAT) or within the abdomen as omental/visceral 
adipose tissue (VAT). In a healthy subject of normal weight, the majority of 
adipose tissue (up to 80%) is represented by SAT and only 10-20% by VAT. 
These depots differ in a number of features such as adipocyte cell size, blood 
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vessel density and immune cell content (9, 10). Adiponectin and peroxisome 
proliferator-activated receptor gamma (PPARγ) are two important adipose tissue-
related proteins. Adiponectin is a secretory protein which is postulated to have 
anti-atherogenic and anti-inflammatory properties (11). PPARγ is a nuclear 
receptor crucial for the differentiation of mesenchymal stem cells into mature 
adipocytes and is important in fatty acids and glucose metabolism. 
The healthy adult adipose tissue is dynamic and changes its size and function 
depending on incoming energy. Extracellular matrix (ECM) remodeling is 
essential to allow rapid adipose tissue responses to a nutrient deficiency or 
surplus. As such, there is constant matrix remodeling, with a balance between 
ECM production and degradation. In obesity, hypertrophic adipocytes which are 
unable to store additional triglycerides start a process of lipolysis with associated 
tissue fibrosis (12). These events lead to enhanced free fatty acid release. These 
free fatty acids may accumulate in other tissues such as the liver, skeletal muscle 
or joints with consequent organ lipotoxicity (13, 14). 
 
Impaired adipocyte function in fat depots, in turn, leads to adipocyte necrosis 
which triggers an influx of pro-inflammatory cells, including hematopoietic cells 
such as macrophages, mast cells, and subtypes of T-cell (15). Significantly, up to 
30% of upregulated genes in adipose tissue in obesity are related to macrophage 
function (16). Increased levels of circulating saturated fatty acids, potent agonists 
of Toll-like receptors (TLR) including TLR2 and TLR4, may also contribute to 
the production of a range of pro-inflammatory and pro-fibrosis mediators 
recognized as being potential targets in OA pathogenesis (17). 
 
In synovial joints, adipose tissue is present in the sub-synoviocyte intimal layer 
and in periarticular depots such as the infrapatellar fat pad (IPFP) of the knee 
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joint. The physiological role of these fat deposits and their origin are not well 
described. It has been suggested that IPFP is similar in type to that of SAT 
deposits (18) due to the fibrous tissue surrounding adipocytes, whereas others 
support a similarity of IPFP to VAT (19).  
The aim of this study was to ascertain whether there were differences in the 
adipose tissue depots of knee joints of obese and non-obese patients who are 
undergoing arthroplasty for end stage OA, in respect to characteristics of SAT and 
VAT and their potential to act as sites of local pro-inflammatory mediator 
production that might contribute to OA progression.  
 
Materials and Methods 
Sample collection 
Ethical approval was granted for the study by Lothian Research Ethics Committee 
and NHS Lothian Research and Development Management, allowing patients 
undergoing primary total knee replacement (TKR) surgery for OA to be 
consented (n=69) for the use of surgical discard tissue for this study. Patients 
were divided into a lean group (with BMI<25) referred to here as Lean and 
patients in class II and III obesity (with BMI of 35 or more) are referred to here as 
Obese. The analyzed samples were isolated by the same surgeon with the same 
incision technique of harvesting synovial punch from the suprapatellar synovial 
region and IPFP from the infrapatellar region. The synovial membrane was not 
separated from the adipose tissue. H&E sections for each patient were analyzed 
and samples with increased synovial membrane (SM) inflammation were not 
analyzed in this study. In general, samples from OA patients had no more than 10-
15% of total SM per the whole tissue biopsy. Lower magnification and example 
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of analyzed areas in histological assessments are presented in Supplementary 
Data. 
 
 
Reagents: 
All reagents were obtained from Sigma Aldrich (UK) unless otherwise stated. 
Antibodies for immunohistochemistry (IHC) were obtained from DAKO (UK) or 
otherwise stated. Flow Cytometry antibodies were obtained from ImmunoTool 
(Germany). Cell culture reagents were from Life Technologies (UK). Antibody 
concentration and negative controls summarized in Supplementary Data. 
Histology, adipocyte area measurement, Picrosirius Red S staining  
Tissues were fixed in 4% PFA, paraffin embedded and cut into 4 µm sections. 
Sections were deparaffinised, rehydrated and stained with H&E or Picrosirius Red 
S stain (PRS). Pictures from 10 different regions (representing 50-150 adipocytes) 
of each sample (n=12 per each group) were taken at a magnification 20x (for 
adipocyte size measurement) and 60x (for PRS) on a Nikon Eclipse E800 
Microscope. Adipocyte size was then assessed by measuring the longest (a) and 
the shortest (b) diameters and using the mathematical formula P = π  ×

		for 
the area of an ellipse to calculate the area of the cell. For quantification of fibrosis 
pictures of PRS stained sections were converted into an 8-bit image with the 
exclusion of the background and the percentage area of fibrosis was calculated. 
For adipocyte size and area of fibrosis measurements ImageJ software was used. 
Immunohistochemistry 
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IHC was performed by incubating sections (n=10 per each group) with the 
primary antibody (anti-hCD45, anti-hCD206 R&D System, anti-hTLR4, Bioss) 
followed by a secondary antibody conjugated with HRP. Chromogenic substrate 
3,3’-Diaminobenzidine (DAB) was used to develop color. Counterstaining was 
performed with Harris Haematoxylin. 
Tissue explant culture and ELISA assays 
Tissues (n=5 per each group) were cut into 1-3mm
3
 fragments, weighed and 
cultured for 24 hours in Iscove’s Modified Dulbecco Medium (IMDM) 
supplemented with 10% Fetal Bovine Serum (FBS) and Pen/Strep. Explants in 
duplicates were then cultivated for 3 days in serum-free IMDM with Pen/Strep 
thereafter supernatants were collected and total adiponectin levels in the media 
assessed using Adiponectin/Arcp30 Quantikine ELISA kit (R&D System). The 
aforementioned kit allowed analysis of Total Adiponectin. The concentration of 
the protein produced was adjusted for the weight of the wet tissue explant (mg). 
Western Blotting 
Tissue samples (n=7 for each group) were snap frozen in liquid nitrogen, 
homogenized and protein concentration was measured by the Bradford Assay 
(Bio-Rad). 25µg of protein from each sample was subjected to 12% sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to PVDF membrane (Immobilon-FL, Millipore, MA) using Bio-Rad Wet Transfer 
system. Blots were blocked by Odyssey Blocking buffer (1:1 with PBS) and 
incubated with the appropriate antibody cocktail (mouse anti-hAdiponectin 1:500 
Peprotech and rabbit anti hGAPDH 1:10000 Sigma Aldrich, or rabbit anti-
hPPARG 1:1000, Santa Cruz and mouse anti-hβ-actin 1:10000, Bioss) diluted in 
Odyssey Blocking buffer (1:1 with PBST) overnight at 4
o
C. Immunoblots were 
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visualized by incubation with fluorescent dye-conjugated secondary antibodies 
cocktail (anti-rabbit IRDYE800CW and anti-mouse IRDYE680RD both 1:10000, 
LiCor) and scanned under infrared Western Blot detection system Odyssey FC® 
Imaging System. For semi-quantitative analysis of protein expression 
densitometry of bands on Western Blots were performed using Image Studio Lite 
3.1 software. Denaturing conditions allowed the analysis of Total Adiponectin in 
the investigated blots. 
RNA isolation, cDNA synthesis, and Real-Time qPCR 
RNA from IPFP and synovium samples (n=7 per each group) was obtained using 
a combined Qiazol and Qiagen Mini RNA isolation kit technique. RNA stability 
was established by gel electrophoresis and 2 bands (28sRNA and 18sRNA) were 
detected. RNA purity was assessed by NanoDrop absorbance measurement with 
260/280 and 260/230 ratio >1.9. 1 µg of RNA was treated with DNAse I 
(Invitrogen) and reverse transcribed by iSCRIPT (Bio-Rad) as per the suppliers’ 
manual. Real Time PCR was conducted on Lightcycler 96 (Roche). 10ng of 
cDNA was analyzed. The primer concentration was 10µM. The reactions were 
performed in triplicates for each analyzed gene. Reactions using SYBRGreen 
chemistry were also subjected to melting curve analysis. Each gene amplification 
curve and efficiency was validated and ranged from 95-105%. Target gene 
expression was normalized with the reference gene β2-microglobulin (β2M). 
Relative mRNA expression was assessed by –∆∆CT method with the lowest Ct 
value served as a calibrator (Livak et al method (20)). The lean sample value was 
used as the reference level and set at 1 in order to analyze fold change.  
Used primer sequences:  
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ADIPOQ Forward GCA TTC AGT GTG GGA TTG GA Reverse TAA AGC 
GAA TGG GCA TGT TG product size 80kb;  
PPARγ Forward GCT GTG CAG GAG ATC ACA GA Reverse GGG CTC CAT 
AAA GTC ACC AA product size 225kb;  
TLR4 Forward AGC TGT ACC GCC TTC TCA GC Reverse CCT GCC AAT 
TGC ATC CTG TA product size 152kb;  
β2M Forward TGT GCT CGC GCT ACT CTC TC Reverse CCA TTC TCT GCT 
GGA TGA CG product size 90kb.  
Flow cytometry  
The stromovascular fraction (SVF) from each tissue explant was obtained as 
follows: 1-3 g of tissue was intensively washed with sterile PBS and minced into 
1-2 mm
3
 pieces and then incubated for 1.5 h at 37
o
C in 2 mg/ml of collagenase I 
and II in 0.5% BSA in Hanks’ Balanced Salt Solution (HBSS) with Ca
2+
 and 
Mg
2+
. The cell fraction was filtered and lysed by Red Cell Lysis Buffer 
(Millipore). Cells were then incubated for 30 min at 4
o
C with anti-hCD-45, anti-
hCD14, and anti-hCD206, antibody or isotype control (1:100 dilution, 
ImmunoTool) and TLR-4 (1:100 dilution Biolegend) in the dark and analyzed by 
flow cytometry (Beckman Coulter XL). The gating strategy is shown in 
Supplementary Data. 
Statistical analyses 
All statistical analysis was performed using GraphPad (Prism 6.0, USA). Mann-
Whitney U test and Wilcoxon matched paired test were used to compare linear 
variables between groups and Spearman rho correlation was used to assess the 
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association between non-parametric linear variables. A Mann-Whitney U test was 
performed for linear variables between groups (lean versus obese) and a 
Wilcoxon matched paired analysis was used to assess differences in linear 
variables between anatomical sites in the same group (IPFP versus synovium 
from the same donor). A p-value of <0.05 was considered to indicate statistical 
significance. 
 
Results 
1. Obesity is associated with changes in adipocyte size and fibrosis in knee joint 
fat depots. 
Histomorphometric analysis demonstrated differences in adipocyte size and 
fibrosis between knee joint fat depots in lean and obese individuals (Figure 1). 
The median size of adipocytes in the synovial adipose tissue of lean individuals 
(5.52 µm
2 
IQR 3.41 to 8.21) was greater (p=0.003) than that of adipocytes in the 
IPFP (4.89 µm
2 
IQR 3.00 to 7.87). This difference was reversed in obese patients 
where the median adipocyte size of adipocytes in the synovial adipose tissue (5.75 
µm
2
 IQR 3.29 to 9.03) was less than that of adipocytes in the IPFP (6.54 µm2 
IQR 3.82 to 9.00) (p<0.0001). Furthermore, there was no significant difference in 
the median adipocyte size in the synovium of lean and obese subjects (p=0.17) 
while in the IPFP, the mean adipocyte size was significantly higher in obese 
compared to lean patients (p<0.0001).  
Analysis of pericellular fibrosis showed no differences in the synovial tissue 
compared to IPFP in lean individuals. Similarly, there was no difference seen 
between IPFP and synovium of obese individuals. However, there was a 
significantly higher area (p<0.005) of matrix deposition in the synovial adipose 
tissue of obese (24.66±5.62%) compared to lean individuals (14.44±5.21%) 
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whereas, there was no significant difference observed in the IPFP (obese 
20.91±8.1%, lean 16.89±3.35%).  The mean adipocyte fibrosis was normalized to 
median adipocyte size in each patient to adjust for adipocyte size difference.  
 
2. Obesity is associated with changes in adipose tissue-related genes and protein 
expression in knee joint fat depots. 
Real Time quantitative PCR and WB analysis showed differential expression of 
adipose tissue-related genes and proteins in the synovium and IPFP in lean and 
obese individuals (Table 1 for qRT PCR and Figure 2 for WB and ELISA). 
The expression of adiponectin gene (ADIPOQ) and protein was not different in 
paired synovium and IPFP samples from lean subjects but was significantly lower 
in synovium compared to IPFP from obese individuals (p=0.02 for qRT-PCR, 
p=0.04 for ELISA and p=0.03 for WB). Furthermore, synovium from lean 
patients expressed significantly higher adiponectin/ADIPOQ (p=0.04 for qRT-
PCR, p=0.03 for ELISA and p=0.004 for WB) than obese subjects but there was 
no such difference in lean versus obese IPFP (Table 1 for qRT PCR and Figure 2 
for WB and ELISA). 
PPARγ gene and protein expression analysis showed significantly lower 
expression in the synovium than in IPFP in lean (p=0.02 for qRT-PCR, p=0.01 for 
WB) but not obese patients. PPARγ was also expressed at a significantly lower 
level in obese patients, both in IPFP (p=0.02 qRT-PCR, p=0.03 for WB) and 
synovium (p=0.04 qRT-PCR, p=0.03 for WB) when compared to lean individuals 
(Table 1 for qRT PCR and Figure 2 for WB). 
3. CD45
+
 hematopoietic cells number and macrophage content of knee joint 
synovium and IPFP is increased with obesity. 
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IHC and flow cytometry analyses showed that the number of 
CD45
+  
hematopoietic cells in the synovial adipose tissue of lean individuals 
(18.7±6.9%) was greater (p=0.03) than IPFP (15.02±6.7%) (Figure 3). CD45
+ 
hematopoietic cells content was elevated in both IPFP (19.4±3.4%) and synovium 
(26.6±8.7%) in obese compared to lean subjects (p=0.04 for IPFP, p=0.004 
synovium) but there was no difference between IPFP and synovium in obese 
subjects. 
Flow cytometry profiling showed that frequency of CD45
+
CD14
+
 total 
macrophages (8.2±3.5% for IPFP, 8.84±2.15% for synovium) and CD14
+
CD206
+
 
M2-type macrophages (6.8±2.2% for IPFP and 5.7±1.6% for synovium) was not 
different between synovium and IPFP of lean individuals (Figure 4). However, 
there was a greater percentage of CD45
+
CD14
+ 
total macrophages (10.6±4.1% for 
IPFP and 12.5±2.8% for synovium) and CD14
+
CD206
+
 M2-type macrophages 
(8.9±3.2% for IPFP and 9.5±2.6% for synovium) in obese individuals both in 
IPFP (p =0.02) and synovium (p=0.0001) for both cell types. CD45
+
CD14
+
 total 
macrophages and CD14
+
CD206
+
 M2-type macrophages content correlated 
significantly with BMI score as summarized in Figure 4.  
4. TLR4 expression is increased in the synovium in obesity and correlates with 
BMI. 
Real Time PCR analysis showed that the TLR4 gene expression was not different 
in synovium and IPFP of lean individuals (Table 1). There was a significantly 
higher expression of TLR4 in the synovium of obese compared to lean subjects 
(p=0.03) however, no difference in TLR4 expression was seen in IPFP of lean and 
obese individuals or between obese IPFP and synovium. Flow cytometry analysis 
showed that the TLR4
+
 cell content did not differ between synovium (4.7±2.3%) 
and IPFP (5.5±4.7%) of lean individuals but was significantly (p=0.009) higher in 
the synovium (9.6±3.7%) of obese compared to lean subjects (Figure 5A). TLR4
+
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cell content correlated with BMI score (Figure 5C). There was no significant 
difference between lean (5.54±4.73%) and obese IPFP (9.0±3.81%) TLR4
+
 cell 
content and no correlation of TLR4
+
 cells with BMI in IPFP (Figure 5B).  
Discussion 
Obesity is a strong risk factor for the development of OA. The association of OA 
in obese patients in both load bearing and non-load bearing joints suggests that 
excessive or abnormal loading of joints does not explain this relationship entirely. 
As such a systemic/metabolic hypothesis has developed which supports the 
hypothesis that metabolic factors related to obesity act directly or indirectly on 
chondrocytes leading to the increased risk of developing OA (21). In the current 
study, we assessed whether there were any differences in the intraarticular fat 
deposits within the knee joint (namely synovium and IPFP) of lean and obese 
individuals undergoing arthroplasty which may indicate a local, in addition to a 
systemic, contribution development and progression of OA. We found that in lean 
individuals, the adipocytes were larger in synovial adipose tissue compared to 
IPFP. There was no difference in pericellular fibrosis or adiponectin expression 
but PPARγ expression was significantly lower in synovium compared to IPFP in 
these patients. A significantly higher content of CD45
+ 
hematopoietic cells was 
identified in synovium compared to IPFP but no differences in macrophage 
number (characterized by CD45
+
CD14
+
 and CD14
+
CD206
+
 expression) and 
TLR4
+
 expression in the fat deposits were seen in lean individuals. In obese 
subjects, adipocyte size was larger in IPFP and pericellular fibrosis was greater in 
synovial fat in comparison to lean individuals. Adiponectin and PPARγ 
expression was lower while TLR4 expression was greater in synovium when 
compared to IPFP of these patients. In both IPFP and synovium of obese patients, 
there was a significantly higher content of CD45
+ 
hematopoietic cells, 
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CD45
+
CD14
+ 
total macrophages, and CD14
+
CD206
+
 M2-type macrophages 
compared to lean subjects with OA.  
A previous study identified the presence of CD86 (M1 type marker) and CD206 
(M2 type marker) by IHC and Flow Cytometry in the IPFP, but did not find the 
influence of BMI on their number (22). A Recent study also found no differences 
in immune cell population between paired IPFP and synovium, however, these 
authors investigated individuals with mean BMI of 28.9 (no more than 32) and 
this may explain the contrasting results to the current study (23).  
Studies of fat deposits in obesity indicate that, with weight gain, adipocytes in 
subcutaneous adipose tissue (SAT) increase in size significantly more than those 
in visceral adipose tissue (VAT) (9). The current study has demonstrated that in 
obese patients, adipocytes in the IPFP significantly increase in size whilst there is 
no change in the size of adipocytes in the synovium.  
Fibrosis, a hallmark of metabolically dysfunctional white adipose with resident 
adipocytes being surrounded by a network of extracellular matrix is typical for the 
visceral fat sampled from obese patients (24). The current study, which has 
demonstrated an increase in adipocyte size in IPFP and pericellular fibrosis in 
synovial fat, supports the theory that synovial and IPFP adipose tissue depots may 
each represent a different subtype of white adipose tissue. The synovial adipose 
tissue demonstrates characteristics akin to those of VAT whereas the IPFP is more 
in keeping with SAT. Conversely, other authors have suggested a pro-fibrotic role 
of the IPFP, which is independent of the BMI index of the patient (25). The 
fibrosis and collagen deposition could have been quantified further in this study 
by using Picosirius Red staining with polarized light to evaluate birefringence. 
Adiponectin has been postulated to be both pro-catabolic (26, 27) and pro-
anabolic (28) in OA. As such the influence of adiponectin on the OA pathogenetic 
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pathway is not clear. The adiponectin concentration has been reported to be 
elevated in the serum of OA patients compared to healthy individuals (29), 
however, levels in synovial fluid are significantly lower than those of peripheral 
blood in OA (30). However, adiponectin levels in synovial fluid have been shown 
to correlate with proteoglycan catabolism [35]. The IPFP has been shown to 
produce more adiponectin than that of subcutaneous depot fat from the same 
donor (6, 31) consistent with the observation of differential expression and 
production of adiponectin by IPFP and synovium in the current study. On the 
other hand, we did not find that adiponectin expression by IPFP correlated 
negatively with BMI of OA patients as suggested by other authors (32).  
Differential expression of adiponectin has also been reported in various kinds of 
adipose tissue depots. SAT produces more adiponectin than VAT (33, 34) and 
during weight gain, a significant downregulation of adiponectin production in 
VAT but not in SAT has been reported (35). We observed a decrease in 
adiponectin gene expression and ex-vivo protein production by synovium but not 
in the IPFP of obese individuals. Although in the present study synovial 
membrane was not dissected from the adjacent adipose tissue, we hypothesize that 
the results obtained may indicate a difference in the origin of the two fatty tissue 
depots analyzed.  
PPARγ is a ligand-activated transcription factor that plays a key role in lipid 
homeostasis. Our data indicate that PPARγ expression was significantly lower in 
both IPFP and synovium of obese patients. Such changes are likely to have a 
proinflammatory/pro-catabolic effect in the joint as PPARγ activation in adipose 
tissue is associated with beneficial effects on the expression and secretion of a 
range of factors, including adiponectin by adipocytes and suppression of 
production of inflammatory mediators such as resistin, IL-6, and TNFα by 
macrophages (36). Notably, mice with a cartilage-specific PPARγ knock-out 
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develop spontaneous OA (37) indicating a role for this transcription factor in the 
regulation of chondrocyte function including inhibition of pro-catabolic pathways 
by supporting autophagy (38). PPARγ agonists have potent anti-inflammatory and 
anti-catabolic activity when applied to articular chondrocytes and synovial 
fibroblasts (39) and have been shown to have some degree of efficacy in 
instability-induced OA models in guinea pigs and dogs (40, 41). Although effects 
of these agents have not yet been shown in human studies, the lower expression of 
PPARγ in the tissues from the knee joint of obese patients indicate that targeted 
therapy for this subgroup of OA patients might be beneficial. 
Leukocyte numbers increase with obesity, both in the circulation and in local 
adipose tissue depots and are correlated with such pro-inflammatory diseases as 
T2DM (42) and liver steatosis (43). Our flow cytometry and IHC data indicate 
that the frequency of hematopoietic cells was significantly higher in the synovium 
in comparison to the IPFP in lean OA patients with a further increase in CD45+ 
cells being seen with obesity suggesting a more pro-inflammatory profile of both 
tissues. The main hematopoietic cells present in adipose tissue are macrophages 
which are postulated to play an important role in obesity-related pro-inflammation 
and organ fibrosis (44). In the current study, we observed for the first time, an 
increased frequency of CD14+CD206+ M2-type macrophages in both knee joint 
synovial and IPFP deposits of obese patients with OA, which correlated 
significantly with BMI. CD206 is considered to be an anti-inflammatory 
macrophage marker. However, M2-type macrophages also play a role in pro-
fibrotic processes during wound healing and are an important source of pro-
fibrotic factor TGF-β (45). This is the very interesting future goal and limitation 
of the current study to determine TGF-β expression in fatty tissue deposits in 
obesity driven OA. 
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The expression of TLR4 and the number of TLR4 positive cells expression were 
significantly increased in the knee joint synovium in obese individuals in 
comparison to lean patients in the current study. In keeping with this, our IHC 
analysis of TLR4 indicated that it was expressed at a significantly higher level in 
the synovial adipose tissue of obese patients compared to lean ones. In humans, 
TLR4 expression is upregulated in obese human VAT but not in SAT (46) 
consistent with our premise that synovial fat deposits in the knee have 
characteristics of VAT. TLR4 plays a crucial role the accumulation of 
macrophages in adipose tissue of obese patients (47). TLR4 ligands activate 
fibroblasts and promote their differentiation into collagen-producing cells (48). 
Moreover, in adipose tissue, it is proposed that interactions between adipocytes 
and macrophages through TLR4/MD-2 aggravates adipose tissue inflammation 
(49) and possibly by such mechanisms could potentiate OA disease progression.  
The analysis of the end-stage OA, the exclusion of patients with a BMI of 
between 30 and 35 and no separation of synovial membrane from adipose tissue 
are potential limitations of this study. However, recent studies and observations 
suggest that BMI is not a perfect index. People classified as obese with BMI 
index of 30 have been shown to have the same or even a better health profile 
compared to those with normal weight (50). A further limitation was the effect of 
comorbidities, such as T2DM, which given the number of patients and subgroups 
it was not possible to evaluate fully in the current study.  
Conclusion.  
The findings of this study show that there are significant differences between 
synovial and IPFP adipose tissue in patients undergoing joint arthroplasty for OA 
which support the theory that synovial fat has characteristics of VAT whilst IPFP 
is more akin to SAT. Obesity is associated with changes in these fat depots, with 
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synovial fat in particular showing changes typical of VAT, which is likely to be 
associated with a pro-inflammatory and catabolic phenotype. Nevertheless, there 
is an increased number of CD45+ hematopoietic cells and CD45
+
CD14
+
 and 
CD14
+
CD206
+
 macrophages in both adipose tissue depots in obese patients which 
supports the idea that in addition to biomechanical factors, local inflammatory 
produced mediators probably contribute to OA in obesity. Targeting this adipose 
dependent inflammation by novel therapies, such as PPARγ agonists, may have a 
benefit and delay OA progression in obese patients. 
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Tables: 
Table 1 Quantitative PCR analysis of ADIPOQ, PPARG and TLR4 gene 
expression in IPFP and synovium obtained from OA patients (n=7 for each 
group). β2M was used to normalize gene expression. -∆∆CT method was used to 
investigate fold change in gene expression. The control values (from lean IPFP 
patients) were expressed as 1 to indicate a precise fold change value (±SEM) for 
each gene of interest. p values < 0.05 were considered significant and indicated 
(a) for p<0.05 in paired analysis (b) p<0.05 in obese vs lean analysis, NS- not 
significant. 
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Figures: 
Figure 1 Representative H&E (A) and Picrosirius Red S (B) staining of adipose 
tissue depots from IPFP and synovium (n=10 for each group). Differences per the 
group and anatomical location are illustrated for median cell size (C). Fibrosis 
percentage normalized to the adipocyte size (D). The mean percentage/median 
um2 adipocyte for group ±SD are presented. p values<0.05 indicated as *, p 
values<0.001 indicated as ***, NS-not significant.  
 
Figure 2 A representative WB blot of Adiponectin (A) and PPARG (B) protein 
expression in IPFP and synovium of OA patients. Semi-quantitative WB analysis 
of Total Adiponectin (C) and PPARγ (D) expression in IPFP and synovium from 
OA patients. Densitometry data is presented as the mean value of the ratios of 
Adiponectin to GAPDH and PPARγ to β-actin expression for each group ± SD 
(n=7 per each group). Ex vivo adiponectin release by IPFP and synovium from 
OA patients (C). p values < 0.05 were considered significant and indicated (a) for 
p<0.05 in paired analysis (b) p<0.05 in obese vs lean analysis, NS- not significant. 
Figure 3 CD45
+
 hematopoietic cells expression in IPFP and synovium from OA 
patients. Flow cytometry (A) and IHC (B) analysis presented. Stromovascular 
(SVF) fractions from IPFP and synovium were analyzed according to CD45
+
 
expression. The isotype control was analyzed at the same time with the sample of 
interest (Gating strategy shown in Supplementary Data). The mean percentage of 
hematopoietic cells for the groups ±SD is shown (A). p value<0.05 indicated as *, 
p value<0.001 indicated as *** NS- not significant. Representative IHC staining 
for CD45 marker in IPFP and synovium from Lean and Obese (B) OA patients. 
Scale bars represents 250um (outer pictures) and 50um (inner pictures). 
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Figure 4 Percentage of CD45
+
CD14
+
, CD14
+
CD206
+
 in SVF fraction of paired 
synovium and IPFP from lean and obese OA patients (A, B). Mean percentages 
for the group ±SD were presented (A,B) n=10 (Lean) and n=14 (Obese) in 
CD45
+
CD14
+ 
detection, n=10 (Lean) n=14 (Obese) in CD14
+
CD206
+ 
detection. 
Correlation of percentage of CD45
+
CD14
+
 and CD14
+
CD206
+
 with BMI score in 
all obtained tissues synovium (n=33) and IPFP (n=26) (A,B). p-value <0.05 
indicated as *, p value<0.005 indicated as **, p value<0.001 indicated as *** NS- 
not significant. Representative IHC staining for CD206 in IPFP and synovium 
from Lean and Obese OA patients (C).  
 
Figure 5 Percentage of TLR4
+
 cells in SVF fraction of paired synovium and IPFP 
from lean and obese OA patients was shown (A). Mean percentages for the group 
±SD n=5 (Lean) and n=5 (Obese) OA patients were presented. Correlation of 
percentage of TLR4 with BMI score in all obtained tissues IPFP (n=15) (B) and 
synovium (n=15) (C). p-value <0.05 indicated as *. NS- not significant. 
Representative IHC staining shown (D). 
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Representative H&E (A) and Picrosirius Red S (B) staining of adipose tissue depots from IPFP and synovium 
(n=10 for each group). Differences per the group and anatomical location are illustrated for median cell size 
(C). Fibrosis percentage normalized to the adipocyte size (D). The mean percentage/median um2 adipocyte 
for group ±SD are presented. p values<0.05 indicated as *, p values<0.001 indicated as ***, NS-not 
significant.  
Figure 1  
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A representative WB blot of Adiponectin (A) and PPARG (B) protein expression in IPFP and synovium of OA 
patients. Semi-quantitative WB analysis of Total Adiponectin (C) and PPARγ (D) expression in IPFP and 
synovium from OA patients. Densitometry data is presented as the mean value of the ratios of Adiponectin 
to GAPDH and PPARγ to β-actin expression for each group ± SD (n=7 per each group). Ex vivo adiponectin 
release by IPFP and synovium from OA patients (C). p values < 0.05 were considered significant and 
indicated (a) for p<0.05 in paired analysis (b) p<0.05 in obese vs lean analysis, NS- not significant.  
Figure 2  
130x76mm (300 x 300 DPI)  
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CD45+ hematopoietic cells expression in IPFP and synovium from OA patients. Flow cytometry (A) and IHC 
(B) analysis presented. Stromovascular (SVF) fractions from IPFP and synovium were analyzed according to 
CD45+ expression. The isotype control was analyzed at the same time with the sample of interest (Gating 
strategy shown in Supplementary Data). The mean percentage of hematopoietic cells for the groups ±SD is 
shown (A). p value<0.05 indicated as *, p value<0.001 indicated as *** NS- not significant. Representative 
IHC staining for CD45 marker in IPFP and synovium from Lean and Obese (B) OA patients. Scale bars 
represents 250um (outer pictures) and 50um (inner pictures).  
Figure 3  
163x73mm (300 x 300 DPI)  
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Percentage of CD45+CD14+, CD14+CD206+ in SVF fraction of paired synovium and IPFP from lean and 
obese OA patients (A, B). Mean percentages for the group ±SD were presented (A,B) n=10 (Lean) and 
n=14 (Obese) in CD45+CD14+ detection, n=10 (Lean) n=14 (Obese) in CD14+CD206+ detection. 
Correlation of percentage of CD45+CD14+ and CD14+CD206+ with BMI score in all obtained tissues 
synovium (n=33) and IPFP (n=26) (A,B). p-value <0.05 indicated as *, p value<0.005 indicated as **, p 
value<0.001 indicated as *** NS- not significant. Representative IHC staining for CD206 in IPFP and 
synovium from Lean and Obese OA patients (C).  
Figure 4  
258x138mm (300 x 300 DPI)  
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Percentage of TLR4+ cells in SVF fraction of paired synovium and IPFP from lean and obese OA patients was 
shown (A). Mean percentages for the group ±SD n=5 (Lean) and n=5 (Obese) OA patients were presented. 
Correlation of percentage of TLR4 with BMI score in all obtained tissues IPFP (n=15) (B) and synovium 
(n=15) (C). p-value <0.05 indicated as *. NS- not significant. Representative IHC staining shown (D).  
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Fold Change (versus Lean IPFP) ADIPOQ PPARG TLR4 
IPFP Lean 1 (±0.75) 1 (±0.43) 1 (±0.13) 
Obese 0.74
 
(±0.56)
 a,NS
 0.35
 
(±0.9)
 a,b
 1.01 (±0.12)
NS,NS
 
Synovium Lean 0.41
 
(±0.51)
 NS,b
 0.25
 
(±0.53)
 a,b
 1.85 (±0.13)
 NS,b
 
Obese 0.09
 
(±0.04)
 a,b
 0.06
 
(±0.62)
 a,b
 3.65 (±0.14)
 NS,b
 
 
Table 1 ADIPOQ, PPARG and TLR4 gene expression analysis by Real Time qPCR in 
IPFP and synovium from Lean and Obese Patients with OA * 
* a – p<0.05 in paired analysis (tissues from the same donor), b – p<0.05 unpaired analysis (in 
obese vs lean donor), NS-non significant 
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